
Canopy Growth CEO ‘really bullish’ on U.S. pot legalization after recent reforms
Smiths Falls-based cannabis firm reported a net loss of nearly $700 million in its fourth quarter, down from a loss of $1.3 billion in the

Canopy Growth CEO ‘really bullish’ on U.S. pot legalization after recent reforms
Smiths Falls-based cannabis firm reported a net loss of nearly $700 million in its fourth quarter, down from a loss of $1.3 billion in the

Hexo strikes $925M deal to buy country’s largest privately held pot producer
Ottawa-based cannabis firm said Friday it will pay $400 million in cash and $525 million in shares for Toronto-based Redecan as it continues to hunt

Hexo eyeing private label strategy as it charts U.S. expansion
CEO of Ottawa-based firm says arrangement would leverage Hexo’s technology to help multi-state operators boost their product quality and margins while lowering costs.

Hexo CEO Sebastien St-Louis said 48North’s strength in topical CBD- and THC-infused creams and ointments was a major selling point as Ottawa firm looks to

Hexo to issue up to $150M in new stock to fund U.S. expansion plans
Ottawa-based pot producer says it also wants to upgrade its plant in Belleville, where it bottles cannabis-infused drinks in a joint venture with brewing giant

How strategic IP helped propel Hexo into a multimillion-dollar cannabis powerhouse
HEXO knew it had to be proactive in securing a strategic portfolio of intellectual property (IP) assets – including patents, trade secrets, trademarks and copyrights.

Cannabis producer Hexo seeks $1.2B capital raise to fund expansion plans
CEO Sebastien St-Louis said the Ottawa-based company is seeking “maximum flexibility” to make acquisitions and sign partnerships with players in related industries.

Hexo cuts Q2 loss after revenue nearly doubled compared with year ago
Ottawa-based cannabis firm reported a loss of $20.8 million in its latest quarter, compared with a loss of $298.2 million in the same period in

U.S. court dismisses class-action lawsuit against Ottawa-based Hexo
Shareholders claimed the pot producer misled them and failed to disclose problems with the business.

Hexo to acquire Zenabis in $235M deal, gain European pot market foothold
The companies believe the deal will help Ottawa-based cannabis producer access the European medical cannabis market through Zenabis’ partnerships.
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
Sponsored
OBJ INSIDER HOLIDAY SAVINGS EVENT. See the full story.